Outcome of the Board Meeting held on 14.11.2025 for considerationa and approval of quarterly results for the quarter and half year ended on 30.09.2025.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Sangal Papers' Board, on Nov 14, 2025, approved unaudited financial results for Q2 and H1 FY26. Q2 revenue from operations stood at Rs. 4,835 lakhs, down about 5.5% from Rs. 5,119 lakhs a year ago. H1 revenue was Rs. 9,592 lakhs versus Rs. 9,379 lakhs in H1 FY25, a modest ~2.3% rise. Profitability, however, weakened sharply: H1 profit after tax fell to Rs. 110.5 lakhs from Rs. 222.7 lakhs (roughly a 50% decline), while Q2 profit crashed to Rs. 30.2 lakhs from Rs. 156 lakhs (about 80% lower). Total expenses, especially raw material costs, grew faster than revenue, squeezing margins. The auditor (Raj Viyom & Co.) issued an unmodified limited review report. Separately, BSE levied Rs. 15,000 in fines for a delayed Integrated Filing-Governance Report submission; the company has filed waiver applications.
Despite steady H1 topline, the steep drop in Q2 earnings reflects significant margin pressure and may dampen investor sentiment. The BSE fine, though small, flags compliance issues. Watch for improvement in raw material costs in coming quarters to gauge a turnaround.